Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
JTT-654, an 11-beta hydroxysteroid dehydrogenase type 1 inhibitor, improves hypertension and diabetic kidney injury by suppressing angiotensinogen production.
J Pharmacol Sci. 2024 Apr;154(4):246-255. doi: 10.1016/j.jphs.2024.02.001. Epub 2024 Feb 2.
J Pharmacol Sci. 2024.
PMID: 38485342
Free article.
An 11-Beta Hydroxysteroid Dehydrogenase Type 1 Inhibitor, JTT-654 Ameliorates Insulin Resistance and Non-obese Type 2 Diabetes.
Heitaku S, Sasase T, Sotani T, Maki M, Katsumi S, Fukuda S, Goto H, Yamamoto H, Nishiu J.
Heitaku S, et al.
Biol Pharm Bull. 2023;46(7):969-978. doi: 10.1248/bpb.b23-00129.
Biol Pharm Bull. 2023.
PMID: 37394647
Free article.
Item in Clipboard
Analysis of haemodynamics and angiogenic response to ischaemia in the obese type 2 diabetic model Spontaneously Diabetic Torii Leprfa (SDT fatty) rats.
Murai Y, Sasase T, Tadaki H, Heitaku S, Imagawa N, Yamada T, Ohta T.
Murai Y, et al. Among authors: heitaku s.
Clin Exp Pharmacol Physiol. 2020 Apr;47(4):583-590. doi: 10.1111/1440-1681.13239. Epub 2020 Jan 16.
Clin Exp Pharmacol Physiol. 2020.
PMID: 31868944
Free article.
Item in Clipboard
Cite
Cite